FDA Extends Approval of PKU Drug to Include Adolescents

Previously only approved for adults, BioMarin’s pegvaliase-pqpz (PALYNZIQ) is now licensed for patients as young as 12 years.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/fda-extends-approval-pku-drug-include-adolescents-2026a10006y2?src=rss

Author :

Publish date : 2026-03-06 11:44:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

FDA Extends Approval of PKU Drug to Include Adolescents

Children With OSA Have Greater Risk for Flu and COVID

Risk Factors for Childbirth-Related PTSS Vary in Parents

Related Posts

FDA’s Controversial Vaccine Chief Exits … Again

Hospitals, Drugmakers, and U.S. Government Continue Battle Over 340B Program

Model Could Sound the Alarm on Preeclampsia Risk in Late Pregnancy

Pre-Op Chemo or Upfront Surgery in Colon Cancer: Is One Strategy Best?

The Chase Is Still On in Heart Pump Innovation

NASA changed an asteroid’s orbit around the sun for the first time

FDA’s Controversial Vaccine Chief Exits … Again

Hospitals, Drugmakers, and U.S. Government Continue Battle Over 340B Program

Model Could Sound the Alarm on Preeclampsia Risk in Late Pregnancy

Pre-Op Chemo or Upfront Surgery in Colon Cancer: Is One Strategy Best?

The Chase Is Still On in Heart Pump Innovation

NASA changed an asteroid’s orbit around the sun for the first time

Myeloma Combo With ‘Unprecedented’ Effect Wins FDA Approval

How Springing Forward to Daylight Saving Time Can Affect Health

Categories

Archives